BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26357470)

  • 1. C-reactive protein levels in stable COPD patients: a case-control study.
    Silva DR; Gazzana MB; Knorst MM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
    Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
    Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
    Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.
    Izquierdo JL; Martínez A; Guzmán E; de Lucas P; Rodríguez JM
    Int J Chron Obstruct Pulmon Dis; 2010 Nov; 5():387-94. PubMed ID: 21103405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
    Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
    Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
    Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
    Wu SJ; Chen P; Jiang XN; Liu ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
    Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.